$379.77
+2.1%Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Last Annual Value
1.12B
3-Year CAGR
40%
5-Year CAGR
16%
10-Year CAGR
22%
| Company | Other Non-Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Waters Corporation NYSE:WAT | 1.12B | 51.2% | 18.7% | 23.3% | |
142.06M | -16.1% | -12.5% | -3.6% | ||
![]() Zimmer Biomet Holdings, Inc. NYSE:ZBH | 870.20M | -2.0% | -7.7% | -0.7% | |
![]() STERIS plc NYSE:STE | 71.70M | -9.6% | -4.0% | -1.6% | |
22.10M | -40.8% | -27.1% | -15.8% | ||
![]() DexCom, Inc. NASDAQ:DXCM | 83.30M | 11.8% | 49.9% | 23.7% | |
![]() Incyte Corporation NASDAQ:INCY | 216.11M | -12.5% | -4.9% | -3.0% | |
![]() Labcorp Holdings Inc. NYSE:LH | -34.80M | N/A | N/A | N/A | |
![]() Illumina, Inc. NASDAQ:ILMN | 360.00M | -16.6% | -17.0% | 5.3% | |
![]() Quest Diagnostics Incorporated NYSE:DGX | 420.00M | -11.5% | -3.5% | -1.0% | |
![]() Medpace Holdings, Inc. NASDAQ:MEDP | -64.29M | N/A | N/A | N/A |
Continue your WAT research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.